382 related articles for article (PubMed ID: 30836062)
1. Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8
Kobayashi T; Oishi K; Okamura A; Maeda S; Komuro A; Hamaguchi Y; Fujimoto M; Takehara K; Matsushita T
J Invest Dermatol; 2019 Jul; 139(7):1535-1544.e1. PubMed ID: 30836062
[TBL] [Abstract][Full Text] [Related]
2. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.
Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T
Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537
[TBL] [Abstract][Full Text] [Related]
3. Plasma Cell Alloantigen 1 and IL-10 Secretion Define Two Distinct Peritoneal B1a B Cell Subsets With Opposite Functions, PC1
Schumacher A; Ehrentraut S; Scharm M; Wang H; Hartig R; Morse HC; Zenclussen AC
Front Immunol; 2018; 9():1045. PubMed ID: 29868008
[TBL] [Abstract][Full Text] [Related]
4. CD43-, but not CD43+, IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses during Chlamydia muridarum genital tract infection.
Moore-Connors JM; Kim HS; Marshall JS; Stadnyk AW; Halperin SA; Wang J
Mucosal Immunol; 2015 Jan; 8(1):94-106. PubMed ID: 24938746
[TBL] [Abstract][Full Text] [Related]
5. A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.
Hsu LH; Li KP; Chu KH; Chiang BL
Cell Mol Immunol; 2015 May; 12(3):354-65. PubMed ID: 25132452
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Subsets of IL-10-Producing Regulatory B Cells in the Course of Tolerance Induction and Maintenance in Islet Allotransplantation.
Li S; Li X; Yang M; Wei L; Wei L; Deng S; Zhao G
Transplant Proc; 2018 Dec; 50(10):3900-3905. PubMed ID: 30577284
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.
Quan S; Sheng JR; Abraham PM; Soliven B
Clin Exp Immunol; 2016 Apr; 184(1):50-61. PubMed ID: 26671281
[TBL] [Abstract][Full Text] [Related]
8. Blimp-1 Contributes to the Development and Function of Regulatory B Cells.
Wang YH; Tsai DY; Ko YA; Yang TT; Lin IY; Hung KH; Lin KI
Front Immunol; 2019; 10():1909. PubMed ID: 31474988
[TBL] [Abstract][Full Text] [Related]
9. Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis.
Xing C; Ma N; Xiao H; Wang X; Zheng M; Han G; Chen G; Hou C; Shen B; Li Y; Wang R
J Leukoc Biol; 2015 Mar; 97(3):547-56. PubMed ID: 25516754
[TBL] [Abstract][Full Text] [Related]
10. B Cells and Melanoma Pathogenesis.
Aira LE; Debes GF
J Invest Dermatol; 2019 Jul; 139(7):1422-1424. PubMed ID: 31230637
[TBL] [Abstract][Full Text] [Related]
11. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
12. Infiltrating regulatory B cells control neuroinflammation following viral brain infection.
Mutnal MB; Hu S; Schachtele SJ; Lokensgard JR
J Immunol; 2014 Dec; 193(12):6070-80. PubMed ID: 25385825
[TBL] [Abstract][Full Text] [Related]
13. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
[TBL] [Abstract][Full Text] [Related]
14. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
15. Antigen-dependent interactions between regulatory B cells and T cells at the T:B border inhibit subsequent T cell interactions with DCs.
Mohib K; Cherukuri A; Zhou Y; Ding Q; Watkins SC; Rothstein DM
Am J Transplant; 2020 Jan; 20(1):52-63. PubMed ID: 31355483
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.
Seo N; Hayakawa S; Takigawa M; Tokura Y
Immunology; 2001 Aug; 103(4):449-57. PubMed ID: 11529935
[TBL] [Abstract][Full Text] [Related]
17. B cell regulation in cancer and anti-tumor immunity.
Sarvaria A; Madrigal JA; Saudemont A
Cell Mol Immunol; 2017 Aug; 14(8):662-674. PubMed ID: 28626234
[TBL] [Abstract][Full Text] [Related]
18. B-1 cells promote immunosurveillance against murine melanoma in host absence of CCR5: new perspective in autologous vaccination therapy.
Vivanco BC; Viana JD; Perez EC; Konno FT; Guereschi MG; Xander P; Keller AC; Lopes JD
Immunobiology; 2014 Nov; 219(11):845-9. PubMed ID: 25104402
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer.
Ishigami E; Sakakibara M; Sakakibara J; Masuda T; Fujimoto H; Hayama S; Nagashima T; Sangai T; Nakagawa A; Nakatani Y; Otsuka M
Breast Cancer; 2019 Mar; 26(2):180-189. PubMed ID: 30244409
[TBL] [Abstract][Full Text] [Related]
20. Astilbin combined with lipopolysaccharide induces IL-10-producing regulatory B cells via the STAT3 signalling pathway.
Xu Y; Wu K; Han S; Ding S; Lu G; Lin Z; Zhang Y; Xiao W; Gong W; Ding Y; Deng B
Biomed Pharmacother; 2020 Sep; 129():110450. PubMed ID: 32768945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
